158 related articles for article (PubMed ID: 35120526)
21. Fibroepithelial lesions; The WHO spectrum.
Krings G; Bean GR; Chen YY
Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
[TBL] [Abstract][Full Text] [Related]
22. Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor.
Cheng CL; Md Nasir ND; Ng GJZ; Chua KWJ; Li Y; Rodrigues J; Thike AA; Heng SY; Koh VCY; Lim JX; Hiew VJN; Shi R; Tan BY; Tay TKY; Ravi S; Ng KH; Oh KSL; Tan PH
Lab Invest; 2022 Mar; 102(3):245-252. PubMed ID: 34819630
[TBL] [Abstract][Full Text] [Related]
23. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions.
Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH
BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027
[TBL] [Abstract][Full Text] [Related]
24. Analysis of histological features in needle core biopsy of breast useful in preoperative distinction between fibroadenoma and phyllodes tumour.
Morgan JM; Douglas-Jones AG; Gupta SK
Histopathology; 2010 Mar; 56(4):489-500. PubMed ID: 20459556
[TBL] [Abstract][Full Text] [Related]
25. Finding an optimum immuno-histochemical feature set to distinguish benign phyllodes from fibroadenoma.
Maity PP; Chatterjee S; Das RK; Mukhopadhyay S; Maity A; Maulik D; Ray AK; Dhara S; Chatterjee J
Micron; 2013 May; 48():34-41. PubMed ID: 23490210
[TBL] [Abstract][Full Text] [Related]
26. Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the Breast.
Yuan M; Saeki H; Horimoto Y; Ishizuka Y; Onagi H; Saito M; Hayashi T; Arakawa A; Yao T
Int J Surg Pathol; 2024 Apr; 32(2):223-229. PubMed ID: 37157807
[No Abstract] [Full Text] [Related]
27. Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.
Lawton TJ; Acs G; Argani P; Farshid G; Gilcrease M; Goldstein N; Koerner F; Rowe JJ; Sanders M; Shah SS; Reynolds C
Int J Surg Pathol; 2014 Dec; 22(8):695-8. PubMed ID: 25161205
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays.
Wang ZC; Buraimoh A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486
[TBL] [Abstract][Full Text] [Related]
29. Recurrent challenges in the evaluation of fibroepithelial lesions.
Giri D
Arch Pathol Lab Med; 2009 May; 133(5):713-21. PubMed ID: 19415945
[TBL] [Abstract][Full Text] [Related]
30. Cytological clues in the distinction between phyllodes tumor and fibroadenoma.
El Hag IA; Aodah A; Kollur SM; Attallah A; Mohamed AA; Al-Hussaini H
Cancer Cytopathol; 2010 Feb; 118(1):33-40. PubMed ID: 20094997
[TBL] [Abstract][Full Text] [Related]
31. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast.
Lee AH; Hodi Z; Ellis IO; Elston CW
Histopathology; 2007 Sep; 51(3):336-44. PubMed ID: 17727475
[TBL] [Abstract][Full Text] [Related]
32. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.
Li JJX; Tse GM
Pathology; 2020 Oct; 52(6):627-634. PubMed ID: 32771211
[TBL] [Abstract][Full Text] [Related]
33. Fibroadenoma With Pleomorphic Stromal Giant Cells: It's Not as Bad as It Looks!
Wawire J; Singh K; Steinhoff MM
Int J Surg Pathol; 2017 Aug; 25(5):425-427. PubMed ID: 28413897
[TBL] [Abstract][Full Text] [Related]
34. Fibroepithelial tumours of the breast-a review.
Lerwill MF; Lee AHS; Tan PH
Virchows Arch; 2022 Jan; 480(1):45-63. PubMed ID: 34505197
[TBL] [Abstract][Full Text] [Related]
35. [Common benign breast tumors including fibroadenoma, phyllodes tumors, and papillary lesions: Guidelines].
Bendifallah S; Canlorbe G
J Gynecol Obstet Biol Reprod (Paris); 2015 Dec; 44(10):1017-29. PubMed ID: 26547891
[TBL] [Abstract][Full Text] [Related]
36. A mother and daughter with phyllodes tumors of the breast.
Foucar CE; Hardy A; Siziopikou KP; Wang L; Parini V; Hansen N; Jeruss JS
Clin Breast Cancer; 2012 Oct; 12(5):373-7. PubMed ID: 22981939
[No Abstract] [Full Text] [Related]
37. Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms.
Jara-Lazaro AR; Akhilesh M; Thike AA; Lui PC; Tse GM; Tan PH
Histopathology; 2010 Aug; 57(2):220-32. PubMed ID: 20716164
[TBL] [Abstract][Full Text] [Related]
38. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
[TBL] [Abstract][Full Text] [Related]
39. microRNAs expression profile in phyllodes tumors of the breast.
Hachana MR; Maatouk M; Lassouad Z; Sriha B; Mokni M
Heliyon; 2024 Jan; 10(2):e24803. PubMed ID: 38312609
[TBL] [Abstract][Full Text] [Related]
40. Localization and hypersecretion of nerve growth factor in breast phyllodes tumors: Evidence from a preliminary study.
Kumar A; Raza K; Nag TC; Srivastava A; Sehgal R
Cancer Rep (Hoboken); 2021 Feb; 4(1):e1300. PubMed ID: 33026185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
